Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") today announced the completion of the acquisition following the receipt of regulatory approval from all government authorities required by the merger agreement.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news